Patients with depression who have an early response with certain symptoms are more likely to have a sustained remission, investigators reported here at the American Psychiatric Association 2007 Annual Meeting.
"At 2 weeks, the improvement on the Hamilton Depression Rating Scale (HAMD) significantly predicted remission for key symptoms with both duloxetine and escitalopram," said principal investigator Martin Katz, PhD, clinical researcher, University of Texas Health Science Center, San Antonio, Texas, United States.
"Improvements for depressed mood, anxiety, and somatic symptoms significantly predicted remission for both treatments," Dr. Katz said in his presentation on May 21st.
READ MORE @ DOCTOR'S GUIDE
Tuesday, May 29, 2007
Subscribe to:
Posts (Atom)
